Saudi pharma giant SPIMACO’s profit rises 25% to $8m in Q1
Follow-ups -eshrag News:
RIYADH: Saudi Pharmaceutical Industries and Medical Appliances Corp., or SPIMACO, has posted a 25 percent rise in profit in the first quarter, compared to the same quarter a year earlier.
Profits of the Saudi-listed firm went up from SR24 million ($6.4 million) to SR31 million, according to a bourse filing.
The increase in profit was driven by a 30 percent growth in gross profit, coupled with a 45 percent increase in operating expenses.
Established in 1986, SPIMACO has been engaged in the medical and pharmaceutical industry, including the development, manufacturing, and distribution of pharmaceutical products and medical appliances.
SPIMACO partners with Vifor Pharma to localize manufacture of key medicine, FerinjectSaudi pharmaceutical company SPIMACO to produce Swiss-firm’s medical treatment amid $64m deal
Noting that the news was copied from another site and all rights reserved to the original source.
